Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Clinical trial NCT03211117 · COMPLETED
Trial details
- NCT number
- NCT03211117
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2018-02-12
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.